These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2989428)

  • 21. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine.
    Abood LG; Salem N; MacNeil M; Butler M
    Biochim Biophys Acta; 1978 Jul; 530(1):35-46. PubMed ID: 210831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Brain Res; 1983 Dec; 289(1-2):223-34. PubMed ID: 6318895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate receptor binding affected differentially by opiates and opioid peptides.
    Childers SR; Creese I; Snowman AM; Synder SH
    Eur J Pharmacol; 1979 Apr; 55(1):11-8. PubMed ID: 220062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of the peripheral opiate receptors in the cat nictitating membrane.
    Enero MA
    Eur J Pharmacol; 1977 Oct; 45(4):349-56. PubMed ID: 200439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct molecular forms of opiate binding in the frog brain.
    Puget A; Jauzac P; Meunier JC
    Life Sci; 1983; 33 Suppl 1():199-202. PubMed ID: 6319860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of high-affinity opioid agonist binding in brain membranes.
    Remmers AE; Medzihradsky F
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2171-5. PubMed ID: 1848695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
    Attali B; Vogel Z
    Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiate receptor thermodynamics: agonist and antagonist binding.
    Hitzemann R; Murphy M; Curell J
    Eur J Pharmacol; 1985 Jan; 108(2):171-7. PubMed ID: 2984022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of anion transport in human red blood cells by 5,5'-dithiobis(2-nitrobenzoic acid).
    Reithmeier RA
    Biochim Biophys Acta; 1983 Jul; 732(1):122-5. PubMed ID: 6871185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T; Wüster M; Gramsch C; Herz A
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain.
    Brase DA; Han YH; Dewey WL
    Diabetes; 1987 Oct; 36(10):1173-7. PubMed ID: 2820820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of opioid receptor binding; possible mechanisms of sulfhydryl groups in the binding site.
    Niwa M; Nozaki M; Fujimura H
    Life Sci; 1983; 33 Suppl 1():211-4. PubMed ID: 6319863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.